Company Milestones

2023
2023
Patent Awarded for “System and Method for inducing Apoptosis in Cancer Cells”

  • Patent Awarded for “System and Method for inducing Apoptosis in Cancer Cells”
2022
2022
  • Initiated direct salesforce
  • Company raised $10.2 million in a private placement
2021
2021
  • Successfully completed phase 1 multi-center clinical trial using Canady Helios Cold Plasma for the treatment of cancer.
  • Published successful results of Canady Helios Cold Plasma used in conjunction with FOLFIRINOX chemotherapy drug.
  • Gained UL manufacturing site approval for production of XL-1000 generator.

Gained UL manufacturing site approval for production of XL-1000 generator.

2020
2020
Launched Canady Plasma XL-1000 Electrosurgical Generator

  • Launched Canady Plasma XL-1000 Electrosurgical Generator
  • Began Canady Helios Cold Plasma Phase 1 clinical trial
  • Canady Helios Cold Plasma HERO system treatment of COVID-19 collaboration with George Washington University
  • Canady Helios Cold Plasma used in compassionate treatment of inoperable retroperitoneal cancer
2019
2019
  • Obtained 510(k) clearance for Canady Plasma XL-1000 Electrosurgical Generator
  • FDA IDE approval for Canady Helios Cold Plasma Phase 1 clinical trial in the U.S.
  • Acquired Endocontrol, robotic surgical company with voice-operated robotics

Acquired Endocontrol, robotic surgical company with voice-operated robotics

2018
2018
  • U.S. patents granted for Canady Helios Cold Atmospheric Plasma
2017
2017
  • Canady Helios Cold Plasma and Hybrid Plasma Scalpels used in the first clinical liver tumor resection
2016
2016
Introduction of Paddle Blade for Canady Hybrid Plasma Scalpel

  • Introduction of Paddle Blade for Canady Hybrid Plasma Scalpel
2015
2015
Received FDA compassionate-use approval for solid tumors using Canady Helios Cold Plasma

  • Received FDA compassionate-use approval for solid tumors using Canady Helios Cold Plasma
2014
2014
  • Released the 2nd generation Canady Hybrid Plasma Scalpel
  • USMI designed and produced the world’s first cold plasma scalpel for cancer treatment.
2013
2013
The world’s first Commercial Cold Plasma Generator System

  • The world’s first Commercial Cold Plasma Generator System was developed at USMI, cold plasma research was accelerated
2012
2012
  • Patent for the Method to generate Cold Plasma was granted by US Patent Office
2011
2011
FDA approval of Canady Hybrid Plasma Scalpel, plasma generators & endoscope

  • FDA approval of Canady Hybrid Plasma Scalpel, plasma generators & endoscope
  • Launch of Cold Plasma Research Program
2009
2009
  • USPI/USMI founded by Jerome Canady, M.D., and partners
  • USMI started a partnership with George Washington University (GWU) and John Hopkins University (JHU)
2008
2008
  • The World‘s First Cold Plasma Treatment For Cancer was developed at George Washington University (GWU) and Johns Hopkins University (JHU)
  • George Washington University (GWU)
  • Johns Hopkins University (JHU)